Depressive Disorder: all 4,847 studies

Page 47 of 49. Open to participants first (509), then studies with results posted, then the rest; newest registration first within each.

• REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN the Treatment of DEPRESSIONStatus unknownNCT00220610Phase 2
• A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant DepressionStatus unknownNCT00220480Not applicable
• Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1CompletedNCT00218556Not applicable
• Low Field Magnetic Stimulation Treatment for Bipolar DepressionTerminatedNCT00217217Phase 3
• Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in DepressionCompletedNCT00215228Phase 2/3
• Modafinil for Atypical DepressionCompletedNCT00215176Phase 2/3
• Beyond Ageing Project: A Study for the Prevention of DepressionCompletedNCT00214682Phase 2
• A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)CompletedNCT00212797Phase 2
• Treatment of Post-TBI DepressionCompletedNCT00211835Not applicable
• Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive DisorderStatus unknownNCT00209807Phase 4
• Characterizing Psychological Consequences of Childhood TraumaCompletedNCT00209105
• Treatment of Reduced Heart Rate Variability Associated With Major Depression With Electroconvulsive TherapyCompletedNCT00209066
• Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?CompletedNCT00208897Not applicable
• Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.CompletedNCT00208715Phase 4
• Thyroid Medication and Antidepressants for Treating Major DepressionCompletedNCT00208702Phase 4
• Abilify Therapy for Reducing Comorbid Substance AbuseCompletedNCT00208169Phase 4
• A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00208156Phase 3
• Risperidone vs. Paroxetine for Panic AttacksTerminatedNCT00206765Phase 2
• Seroquel in Bipolar Depression Versus LithiumCompletedNCT00206141Phase 3
• The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic CapacityCompletedNCT00205946Phase 1
• Behavioral Processes Underlying Reward Processing in DepressionCompletedNCT00205933
• Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or DependenceWithdrawnNCT00204503Phase 2
• Treatment for Chronic DepressionTerminatedNCT00204152Phase 3
• Use of Risperidone in ECT for Treatment Resistant DepressionTerminatedNCT00203723Phase 4
• Carbamazepine Extended-Release for the Treatment of Bipolar DepressionCompletedNCT00203567Phase 4
• The Effect of Testosterone on Mood and Quality of LifeCompletedNCT00202462Not applicable
• Acute, Affective, Organic Disorders.CompletedNCT00201474
• Aripiprazole Treatment of Bipolar DepressionCompletedNCT00198198Phase 4
• Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus RibavirinCompletedNCT00196664Phase 3
• Switching to Duloxetine From Other AntidepressantsCompletedNCT00191932Phase 4
• A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainCompletedNCT00191919Phase 3
• Duloxetine in the Treatment of Melancholic DepressionCompletedNCT00191685Phase 3
• Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine TrialsCompletedNCT00191594Phase 3
• Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment ResponseCompletedNCT00191399Phase 4
• A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderCompletedNCT00191061Phase 4
• Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression (rTMS)TerminatedNCT00190216Phase 3
• A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar DisorderCompletedNCT00188942Phase 4
• Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment ResponseCompletedNCT00188396Not applicable
• Transcranial Magnetic Treatment (TMS) in Unipolar DepressionCompletedNCT00186784Early Phase 1
• Acupuncture and Massage for Depression During PregnancyCompletedNCT00186654Phase 2
• Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?CompletedNCT00186264Not applicable
• Duloxetine for the Treatment of DysthymiaCompletedNCT00185575Not applicable
• The Immune System and Psychiatric DisordersCompletedNCT00184418
• Effects of Psychoeducation of Relatives to Patients With Serious Mental IllnessCompletedNCT00184379Not applicable
• Understanding Brain Reward Responses in Individuals With Major Depressive DisorderCompletedNCT00183755
• Preventing Depression Relapse With Mindfulness-Based Cognitive TherapyCompletedNCT00183560Phase 4
• Depression Prevention Program for American Indian Adolescents During and After PregnancyCompletedNCT00183547Not applicable
• Family Cognitive Behavioral Therapy for Preventing Depression in ChildrenCompletedNCT00183482Not applicable
• Depression Prevention Program for AdolescentsCompletedNCT00183417Not applicable
• Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersTerminatedNCT00182533Phase 4
• Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar DisorderTerminatedNCT00181896Phase 4
• Sertraline vs. Venlafaxine XRCompletedNCT00179283Phase 3
• The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to EscitalopramCompletedNCT00179257Phase 3
• Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant DepressionCompletedNCT00179244Phase 3
• Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar DisorderCompletedNCT00179062Not applicable
• MRI Imaging of Chronobiologic Abnormalities in DepressionCompletedNCT00178880
• Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With DepressionCompletedNCT00178100Phase 4
• The Effects of Sleep Deprivation on Antidepressant ResponseCompletedNCT00178074Phase 4
• Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly IndividualsCompletedNCT00178035Phase 4
• Pharmacotherapy in Depression With Panic SpectrumCompletedNCT00177996Phase 4
• Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major DepressionCompletedNCT00177528Phase 4
• Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation OutcomesTerminatedNCT00177424Phase 4
• Aripiprazole as Augmentation for TRDCompletedNCT00174876Phase 2
• Treatment of Depression With QuetiapineTerminatedNCT00174603Phase 3
• Treatment of Major Depressive Disorder With Psychotic Features.TerminatedNCT00174590Phase 3
• Mastery, Social Support and Depression of Patients With Major DepressionCompletedNCT00172848
• Organized Self-management Support for Chronic DepressionCompletedNCT00169286Not applicable
• Epidemiology and Care of Comorbid Obesity and DepressionCompletedNCT00169273Not applicable
• The Neurobiology of Depressive IllnessStatus unknownNCT00168493Not applicable
• A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive DisorderCompletedNCT00168376Not applicable
• Priming rTMS In Major DepressionCompletedNCT00168272Not applicable
• Risperidone and Suicidality in Major Depressive DisorderCompletedNCT00167154Phase 3
• The Feelings Club: Evaluating a School-based Intervention for Children at Risk for Depression and Anxiety DisordersCompletedNCT00164203Not applicable
• The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDDCompletedNCT00163059Phase 2
• Antidepressant Maintenance in Traumatic Brain InjuryStatus unknownNCT00162916Phase 4
• Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major DepressionTerminatedNCT00159146Not applicable
• Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.CompletedNCT00158990Phase 3
• Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and AdolescentsCompletedNCT00158301Not applicable
• Combined Interventions for Treating Depression and Chronic Back PainCompletedNCT00158275Not applicable
• Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in DepressionCompletedNCT00157547Phase 4
• Psychiatric Day Hospital TreatmentCompletedNCT00153959Not applicable
• The Efficacy and Safety of Escitalopram for Depression in Multiple SclerosisTerminatedNCT00151294Phase 4
• Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive TherapyCompletedNCT00150839Phase 4
• Chronos: the Use of Chronobiological Treatment in DepressionCompletedNCT00149110Not applicable
• An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00146523Phase 3
• Reducing the Risk of Developing Major Depression in Adolescents/Young Adults With Minor Depression/Depression SymptomsTerminatedNCT00145951
• Primary Care Based Depression Prevention for Adolescents/Young Adults/Young Adults and Young AdultsCompletedNCT00145912Not applicable
• Beta-CIT-SPECT and Neurophysiology in DepressionCompletedNCT00145132Phase 4
• Study of a Self-Help Depression Skills Program for College-Aged YouthCompletedNCT00145054Phase 2/3
• Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive DisorderTerminatedNCT00143091Phase 2
• DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary SyndromeStatus unknownNCT00140257Phase 4
• Automated Telephone System to Improve Treatment Adherence in People With DepressionCompletedNCT00136240Not applicable
• Study of BMS-562086 in the Treatment of Outpatients With Major Depressive DisorderCompletedNCT00135421Phase 1/2
• A United States Study of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00130676Phase 3
• Treatment of Depression in the ElderlyTerminatedNCT00130455Phase 4
• An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128505Phase 3
• A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128479Phase 3
• Metyrapone as Additive Treatment in Major DepressionCompletedNCT00125554Phase 2
• An Evaluation of the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to DepressionCompletedNCT00122083Not applicable
• Deep Brain Stimulation for Treatment-Refractory Major DepressionCompletedNCT00122031Phase 1

← Depressive Disorder overview